₹67.20 crores from anchor investors ahead of its initial public offering that opens for public subscription on Thursday, February 29, 2024. The company informed the bourses that it allocated 2,39,99,565 equity shares at ₹28 per share on Wednesday, February 28, 2024, to six anchor investors.
Anchor investors who participated in the anchor were Neomile Growth Fund, Saint Capital Fund, Zinnia Global Fund PCC, Eminence Global Fund PCC, Craft Emerging Market Fund PCC, and Elara India Opportunities Fund. Also read: Mukka Proteins IPO opens tomorrow: GMP, issue details, 10 key things to know before investing to ₹224-crore issue Fedex Securities Private Limited is the sole book-running lead manager and Cameo Corporate Services Limited is the registrar to the offer.
The equity shares are proposed to be listed on the BSE and NSE. The issue consists of a fresh issue of up to 8 crore equity shares with no offer for sale (OFS) component. The company is proposing to open its initial public offering of equity Shares on Thursday, February 29, 2024, and closes on Monday, March 04, 2024.
The price band for the offer has been determined at ₹26 – ₹28 per equity share. The IPO will fetch ₹224 crore at the upper end of the price band.
Investors can bid for a minimum of 535 equity shares and in multiples of 535 equity shares thereafter. Also read: Platinum Industries IPO: Planning to invest? Here are 10 key things to know from RHP before subscribing The company intends to use the net proceeds from the issue, as stated in the red herring prospectus (RHP), to fund the following: general corporate purposes, investment in their associate, Ento Proteins Private Limited, to fund its working capital requirements, and funding the company's working
. Read more on livemint.com